A cellular and molecular understanding of psoriasis
Researchers gained new insights into the cellular and molecular features of psoriasis, an inflammatory skin disease. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - June 13, 2023 Category: Consumer Health News Source Type: news
EULAR Offers Tips on Psoriasis Progression to PsA
(MedPage Today) -- Clinicians treating patients with psoriasis should be on the lookout for certain signs that joint involvement is likely to develop, according to a new "points to consider" document from the European Alliance of Associations for... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - June 12, 2023 Category: Dermatology Source Type: news
Study Addresses Psoriasis Pregnancy Outcomes, Fertility Study Addresses Psoriasis Pregnancy Outcomes, Fertility
The study included data on over 63,000 women with psoriasis in a UK database and is believed to be one of the largest studies to investigate fertility and obstetric outcomes in this population.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 12, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
TREMFYA ® (guselkumab) Provides Sustained Improvements Across All Minimal Disease Activity Domains for Adults Living with Active Psoriatic Arthritis in Phase 3b Trial
SPRING HOUSE, PENNSYLVANIA, May 31, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 3b COSMOS clinical trial showing that treatment with TREMFYA® (guselkumab) provided sustainable improvements in all minimal disease activity (MDA)a domains through week 48 in adults living with active psoriatic arthritis (PsA) who previously had an inadequate response to one to two tumor necrosis factor inhibitors (TNFi-IR).[1] In a separate post-hoc analysis of the Phase 3 DISCOVER-1 and DISCOVER-2b clinical trial findings, TREMFYA was shown to be associated with prompt and su...
Source: Johnson and Johnson - May 31, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Psoriasis Biosimilars Appear to Match Up to Original Products, With Caveats
(MedPage Today) -- Biosimilars for psoriasis matched the performance of the original products for skin clearance, but evidence from real-world comparisons remains limited, a systematic review of published studies showed.
No clinically or statistically... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 31, 2023 Category: American Health Source Type: news
S2 Episode 3: Surfacing Synergistic Solutions for Limited Psoriasis S2 Episode 3: Surfacing Synergistic Solutions for Limited Psoriasis
Drs Steven R. Feldman and Kim A. Papp discuss the expanding universe of opportunities and advances for halting limited psoriasis.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 25, 2023 Category: Consumer Health News Tags: Dermatology InDiscussion Source Type: news
Amgen Settles Patent Lawsuit Over Biosimilar of Stelara Amgen Settles Patent Lawsuit Over Biosimilar of Stelara
Johnson& Johnson has settled its lawsuit over Amgen ' s proposed biosimilar version of J&J ' s top-selling treatment Stelara for psoriasis and other autoimmune conditions, according to a filing in Delaware federal court.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 25, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Shoppers share how food supplement TRANSFORMED their psoriasis
SHOPPING: People who suffer from psoriasis have shared how a food supplement has helped transform their skin in dramatic before and after photos. (Source: the Mail online | Health)
Source: the Mail online | Health - May 24, 2023 Category: Consumer Health News Source Type: news
Life-threatening psoriasis left mum looking like 'burns victim' - until she found cure
Linzi Dunlevy's skin was so "raw" she used to wake up at 4.00 am so she could have a bath just to cool down her skin. (Source: Daily Express - Health)
Source: Daily Express - Health - May 21, 2023 Category: Consumer Health News Source Type: news
Life-threatening psoriasis left mum looking like 'burns victim' - until she found remedy
Linzi Dunlevy's skin was so "raw" she used to wake up at 4.00 am so she could have a bath just to cool down her skin. (Source: Daily Express - Health)
Source: Daily Express - Health - May 21, 2023 Category: Consumer Health News Source Type: news
First Phase 3 TREMFYA ® (guselkumab) Data in Inflammatory Bowel Disease Show Positive Induction Results Among Patients with Moderately to Severely Active Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, May 9, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new efficacy and safety data from the Phase 3 QUASAR Induction Study evaluating the investigational use of TREMFYA® (guselkumab) in adults with moderately to severely active ulcerative colitis (UC)a who had an inadequate response or intolerance to conventionalb and/or advanced therapies.1,c The data show statistically significant and clinically meaningful improvements across symptomatic and histo-endoscopic outcome measures.1 Safety data were also consistent with the known safety profile of TREMFYA in ...
Source: Johnson and Johnson - May 9, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Scientists recruit 2,000 Britons to find a link between psoriasis and arthritis
Psoriasis causes red, flaky and itchy patches of skin all over the body, and studies show that around a third of sufferers will also eventually be diagnosed with the painful joint condition. (Source: the Mail online | Health)
Source: the Mail online | Health - May 6, 2023 Category: Consumer Health News Source Type: news
Four surprising lifestyle factors that could 'worsen psoriasis symptoms'
Dr Barbara Kubicka offered advice about the skin condition psoriasis a chronic skin condition that causes red, scaly patches on the skin (Source: Daily Express - Health)
Source: Daily Express - Health - April 30, 2023 Category: Consumer Health News Source Type: news
Lung drug proved to ease the pain of psoriasis is providing relieve for three quarters of patients
Following successful study results, the treatment has now been approved for use in the US in patients aged nine and over by drug watchdog the FDA. (Source: the Mail online | Health)
Source: the Mail online | Health - April 29, 2023 Category: Consumer Health News Source Type: news
S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression? S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?
Dr Steve Feldman speaks with Drs Mehta, Ritchlin, and Fried who share an exciting new roadmap for calming key psoriasis comorbidities.Medscape (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - April 25, 2023 Category: Orthopaedics Tags: Dermatology InDiscussion Source Type: news
